Skip to search formSkip to main contentSkip to account menu
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.
TLDR
It is shown that neutralization level is highly predictive of immune protection, and an evidence-based model of SARS-CoV-2 immune protection that will assist in developing vaccine strategies to control the future trajectory of the pandemic is provided.
View on PubMed
Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation
TLDR
It is demonstrated that long-lived intraepithelial CD103+CD8+ TRM cells can be generated and survive in the absence of in situ antigen recognition and provide a powerful means of achieving immune protection against peripheral infection.
View on Publisher
Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies.
TLDR
Key ADE mechanisms are described and mitigation strategies for SARS-CoV-2 vaccines and therapies in development are discussed and recently published data is outlined to evaluate the risks and opportunities for antibody-based protection against Sars-Cov-2.
View on PubMed
Rapid Viral Escape at an Immunodominant Simian-Human Immunodeficiency Virus Cytotoxic T-Lymphocyte Epitope Exacts a Dramatic Fitness Cost
TLDR
This data indicates that reversion to wild type can occur following transmission to MHC-mismatched hosts in the absence of cytotoxic T-lymphocyte (CTL) pressure, due to the reduced fitness of the escape mutant virus.
View on Publisher
Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells
TLDR
A multipronged approach was undertaken to investigate which molecules are necessary for pAg detection by Vγ9Vδ2 T cells and the top candidate molecule identified in the genome-wide screen was butyrophilin 2A1 (BTN2A1), a molecule distinct from, but related to, BTN3A1.
View on Publisher
Cross-Reactive Influenza-Specific Antibody-Dependent Cellular Cytotoxicity Antibodies in the Absence of Neutralizing Antibodies
TLDR
It is concluded that there is a remarkable degree of cross-reactivity of influenza-specific ADCC Abs in seropositive humans, which could lead to improved influenza vaccines.
View on Publisher
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
TLDR
It is indicated that SARS-CoV-2 immunity after infection might be transiently protective at a population level and might require greater immunogenicity and durability than natural infection to drive long-term protection.
View on Springer
Enhanced T-Cell Immunogenicity and Protective Efficacy of a Human Immunodeficiency Virus Type 1 Vaccine Regimen Consisting of Consecutive Priming with DNA and Boosting with Recombinant Fowlpox Virus
TLDR
These studies suggest a safe strategy for the enhanced generation of T-cell-mediated protective immunity to HIV-1, and a consecutive immunization strategy involving priming with DNA and boosting with rFPV vaccines encoding common HIV- 1 antigens is evaluated.
View on ASMUSA
Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection
TLDR
An elevated diffuse serum inflammatory cytokine profile in symptomatic long COVID subjects that was maintained at 8 months post-infection and was not observed in asymptomatic COVID-19 survivors is found.
View on PubMed
Antibody-Dependent Cellular Cytotoxicity Is Associated with Control of Pandemic H1N1 Influenza Virus Infection of Macaques
TLDR
It is shown that seasonal infection of influenza-naïve Indian rhesus macaques with A/Kawasaki/173/2001 (sH1N1) virus induces antibodies capable of binding the hemagglutinin of both the homologous seasonal virus and the antigenically divergent A/California/04/2009 strain in the absence of detectable H1N 1pdm-specific neutralizing antibodies.
View on ASMUSA
...
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License